{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T06:14:02Z","timestamp":1698387242882},"reference-count":45,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2009,8,26]],"date-time":"2009-08-26T00:00:00Z","timestamp":1251244800000},"content-version":"vor","delay-in-days":5163,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Fundamemntal Clinical Pharma"],"published-print":{"date-parts":[[1995,7,8]]},"abstract":"<jats:p><jats:bold>Summary\u2014<\/jats:bold> In order to test whether the \u03b2\u2010adrenoceptor activity in rheumatic heart valvular disease depends on the ventricular load conditions, we determined their density and binding affinity to [<jats:sup>125<\/jats:sup>I]\u2010iodocyanopindolol in lymphocytes, as well as plasma catecholamine and cAMP levels in 69 patients with regurgitant and stenotic lesions of the aortic and mitral valves. The patients were classified as having left ventricular pressure overload (LVP), left ventricular volume overload (LVV), mixed lesions (MOL) or right ventricular pressure overload (RVP). The \u03b2\u2010adrenoceptor activity was determined by radioligand binding methods, catecholamines by high performance liquid chromatography using an electrochemical detector and cAMP by radioimmunoassay. The mean \u03b2\u2010adrenoceptor density (B<jats:sub>max<\/jats:sub>) of the control group was 60.1 \u00b1 9.5 \/mol (<jats:italic>n<\/jats:italic> = 29) per 10<jats:sup>6<\/jats:sup> lymphocytes. In the study population, the density was decreased by 83% in LVP, 78% in LVV, 87% in MOL and 86% in RVP. Plasma norepinephrine was elevated by 89% in LVP and 60% in MOL, epinephrine by 43% in LVP, 50% in VOL, 115% in MOL and 20% in RVP, while dopamine was not significantly changed, and cAMP was slightly elevated in all four groups. Screening for activating mutational changes in the G<jats:sub>s\u03b1<\/jats:sub>\u2010protein gave negative results, possibly dissociating the elevation in plasma cAMP from stimulatory effects of such abnormalities in the G<jats:sub>s<\/jats:sub>\u2010protein signaling. These results show a significant attenuation in lymphocyte \u03b2\u2010adrenoceptor density of patients with rheumatic heart valvular disease, irrespective of the type of the prevailing ventricular load conditions. The reduction in receptor density is accompanied by a significant increase in plasma norepinephrine levels in patients with a left ventricular pressure overload and epinephrine in those with volume overload.<\/jats:p>","DOI":"10.1111\/j.1472-8206.1995.tb00512.x","type":"journal-article","created":{"date-parts":[[2009,8,26]],"date-time":"2009-08-26T17:20:05Z","timestamp":1251307205000},"page":"372-380","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Characterization of lymphocyte \u03b2\u2010adrenoceptor activity and G<sub>s<\/sub>\u2010protein in patients with rheumatic heart valvular disease"],"prefix":"10.1111","volume":"9","author":[{"given":"N.","family":"Dzimiri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Moorji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Prabhakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Bakr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AA","family":"Almotrefi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Halees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,8,26]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"360","article-title":"A study of the factors affecting the aluminium oxide trihydroxyindole procedure for the analysis of catecholamines","volume":"38","author":"Anton AH","year":"1962","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_3_1","first-page":"24","article-title":"Beta2\u2010adrenergic receptors on peripheral blood mononuclear cells in patients with rheumatic diseases","volume":"22","author":"Baerwald C.","year":"1992","journal-title":"Eur J Clin Invest"},{"key":"e_1_2_1_4_1","first-page":"528","volume-title":"Principles and practice of infectious diseases","author":"Bisno A.","year":"1990"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.82.4.1249"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198207223070401"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2828(85)90007-0"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.59.3.297"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.82.2.658"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199212000-00015"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198611000-00021"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(90)90060-B"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(89)90181-2"},{"key":"e_1_2_1_14_1","first-page":"1059","article-title":"A new constitutively activating mutation of the Gs protein \u03b1 subunit\u2010gsp oncogene is found in human pituitary tumours","volume":"5","author":"Clementi E.","year":"1990","journal-title":"Oncogene"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198409273111303"},{"key":"e_1_2_1_16_1","first-page":"144","article-title":"In vivo studies of myocardial \u03b2\u2010adrenergic receptor pharmacology in patients with congestive heart failure","volume":"82","author":"Colucci WS.","year":"1990","journal-title":"Circulation"},{"key":"e_1_2_1_17_1","first-page":"I35","article-title":"Myocardial catecholamine and the pathophysiology of heart failure","volume":"82","author":"Daly PA","year":"1990","journal-title":"Circulation"},{"key":"e_1_2_1_18_1","first-page":"119","article-title":"Alpha\u2010adrenoceptor activity in patients with rheumatic heart valvular disease","volume":"72","author":"Dzimiri N.","year":"1994","journal-title":"Can J Physiol Pharmacol"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1006\/cbir.1993.1135"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.70.4.688"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113569"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.74.6.1290"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI111179"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.56.070187.003151"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.ph.53.030191.001033"},{"key":"e_1_2_1_26_1","first-page":"I26","article-title":"Mechanism of abnormal transmembrane signalling of the \u03b2\u2010adrenergic receptor in congestive heart failure","volume":"82","author":"Horn EM","year":"1990","journal-title":"Circulation"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(86)90150-4"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.ne.15.030192.000511"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/340692a0"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/1043-6618(91)90117-G"},{"key":"e_1_2_1_31_1","first-page":"62","article-title":"\u03b1\u2010adrenergic receptors in heart failure","volume":"5","author":"Lee AH.","year":"1989","journal-title":"Heart Failure"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-351X(05)80178-8"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114460"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(92)90012-A"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)92601-3"},{"key":"e_1_2_1_36_1","first-page":"309","article-title":"Heart and catecholamines","author":"Prichard BNC","year":"1991","journal-title":"Acta Cardiol"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1089\/dna.1992.11.1"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-13-3-536"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4612-0463-3_1"},{"key":"e_1_2_1_40_1","first-page":"67","volume-title":"\u03b2\u2010adrenoceptors: molecular biology, biochemistry and pharmacology. Progress in basic and clinical pharmacology","author":"Stadel JM.","year":"1991"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00265923"},{"key":"e_1_2_1_42_1","first-page":"1417","article-title":"Cyclic AMP and contractile activity in the heart","volume":"65","author":"Tsien RW.","year":"1989","journal-title":"Adv Cyclic Nucl Res"},{"issue":"6","key":"e_1_2_1_43_1","first-page":"S18","article-title":"Adrenergic and muscarinic receptors: classification, pathophysiological relevance and drug target","volume":"9","author":"Zwieten PA.","year":"1991","journal-title":"J Hypertens"},{"key":"e_1_2_1_44_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI111351"},{"key":"e_1_2_1_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/0009-9120(93)90109-J"},{"key":"e_1_2_1_46_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199112123252403"}],"container-title":["Fundamental &amp; Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1472-8206.1995.tb00512.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1472-8206.1995.tb00512.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T04:51:08Z","timestamp":1698295868000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1472-8206.1995.tb00512.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,7,8]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1995,7,8]]}},"alternative-id":["10.1111\/j.1472-8206.1995.tb00512.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1472-8206.1995.tb00512.x","archive":["Portico"],"relation":{},"ISSN":["0767-3981","1472-8206"],"issn-type":[{"value":"0767-3981","type":"print"},{"value":"1472-8206","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,7,8]]},"assertion":[{"value":"2009-08-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}